Antihypertensive agents in renal disease.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001834:Body Water / Q000187:drug effects; D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006977:Hypertension, Renal / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000628:therapy; D008750:Methyldopa / Q000627:therapeutic use; D006435:Renal Dialysis; D012083:Renin / Q000097:blood; D012110:Reserpine / Q000627:therapeutic use; D012504:Saralasin / Q000627:therapeutic use; D013722:Teprotide / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D008750:Methyldopa; D005665:Furosemide; D012110:Reserpine; D013722:Teprotide; D012083:Renin; D012504:Saralasin; D004976:Ethacrynic Acid; D003000:Clonidine; D003981:Diazoxide; D006145:Guanethidine